Severe Sepsis Terminated Phase 4 Trials for Dexmedetomidine (DB00633)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02109965The Effect of Dexmedetomidine on Microcirculation in Severe SepsisBasic Science